Determining the Relation of Depression, Anxiety, and Quality of Life with Outcome after Percutaneous Transluminal Coronary Angioplasty| Chapter 9 | Current Innovations in Medicine and Medical Science Vol. 10

 Background: The arrival of Percutaneous Transluminal Coronary Angioplasty (PTCA) was a turning point in the situation of Coronary Heart Diseases. The psychiatric sequelae of PTCA, though suitable, have not happened sufficiently intentional.Methods: Thirty-five patients meeting with PTCA were included in this place study. Before the procedure, they suffused a proforma constituting sociodemographic analyses, Hospital Anxiety and Depression Scale (HADS), Coronary Scale, Seattle Angina Questionnaire (SAQ) and a Health-related Quality of Life measure (EQ5D). Three days post-process, the patients were occasionally required to fill HADS, Coronary Scale, SAQ and EQ5D.Results: Significant worry and significant concavity were present in 46% and 32.1% of the patients before PTCA, individually. After PTCA, none had meaningful anxiety, and only 2 (3.6%) patients had important depression. The SAQ mirrored an improvement in material limitation from 67.9 to 48; in affliction perception from 21.2 to 36.1. The EQ5D mirrored an improvement in well-being status from 42.7 to 78.7.Conclusion: PTCA, if favorably done, can influence a significant decline in anxiety, cavity, physical restraint, and can cause an improved well-being perception and fitness status.

Author(s) Details:

Suprakash Chaudhury,
Department of Psychiatry, Dr. D Y Patil Medical College, Hopsital and Research Centre, Pimpri, Pune, Maharashtra, India.

Stuti Saxena,
Department of Psychiatry, Armed Forces Medical College, Pune, Maharashtra, India.

Tahoora Ali,
Department of Psychiatry, Dr. D Y Patil Medical College, Hopsital and Research Centre, Pimpri, Pune, Maharashtra, India.

Kalpana Srivastava,
Department of Psychiatry, Armed Forces Medical College, Pune, Maharashtra, India.

Please see the link here: https://stm.bookpi.org/CIMMS-V10/article/view/8869

Determining the Effects of Methanolic Extracts of Quisqualis indica on Passive Smoking Induced Hyperlipidemia in Rats| Chapter 1 | Challenges and Advances in Pharmaceutical Research Vol.3

The hypolipidemic effect of methanolic and aqueous extracts of aerial portions of Quisqualis indica (QI), mostly flowers, on passive smoking (PS) induced hyperlipidemia in rats will be compared in this study. Hyperlipidemia was generated by passive smoking in a closed room with one burning cigarette inside. After treatment with the reagent contained in the auto span diagnostic kit, the hypolipidemic activity was assessed by detecting the amount of blood serum in UV at 505 nm. A dosage of Methanolic and aqueous extracts of QI was generated using distilled water, i.e. 100 mg/kg p.o. At varying concentrations and dosages, both QI extracts significantly reduce the hazardous lipid layer in blood serum. This indicates that the plant possesses hypolipidemic properties. It significantly reduces LDL, VLDL, cholesterol, triglycerides, and elevates HDL levels in blood serum, which might be due to the plants' antioxidants suppressing lipid peroxidation. Our findings suggest that methanolic plant extracts are superior than aqueous extracts in terms of reducing harmful lipids and restoring lipid metabolism abnormalities in hyperlipidemic patients.

Author(s) Details:

Jyoti Sahu,
Bharat Institute of Technology, Ibrahimpatnam and Siddhi Vinayak Institute of Technology, Bilaspur, Chhattisgarh, India.

Pushpendra Kumar Patel,
Bharat Institute of Technology, Ibrahimpatnam and Siddhi Vinayak Institute of Technology, Bilaspur, Chhattisgarh, India.

Please see the link here: https://stm.bookpi.org/CAPRV-3/article/view/6941

Reaching LDL-C Goals Using Nudges: A Review of Literatures | Chapter 08 | New Horizons in Medicine and Medical Research Vol. 5

 To analyse the literature and determine how nudges can assist a physician in meeting his or her patients' LDL-C targets. Modifying cardiovascular risk factors can help lower the rate of coronary events in high-risk patients. In the United States and most European countries, coronary heart disease is the leading cause of mortality (CHD). Hypercholesterolemia is the most important risk factor for coronary artery disease. Both high-density lipoprotein (HDL-C) and low-density lipoprotein (LDL-C) are major risk factors for coronary artery disease (CHD). HMG-CoA inhibitors are the most effective medication for lowering LDL-C levels and, as a result, reduce cardiovascular mortality and morbidity. When a decision architecture is built to consistently control behaviour without limiting an individual's choices, it is referred to as a nudge. In order to be effective, the direction and force of a nudge should be compatible with professional standards. The essay discussed how patients' and physicians' actions contributed to the rise in cardiovascular disease prevalence. Nudges, whether digital or manual (using post-its), can persuade doctors to be more proactive and increase patient adherence to therapy. The patient-physician relationship must be built on trust in order to attain these goals. Nudges can be a useful management technique for guiding healthcare providers' right behaviour. The goal is to persuade doctors that they are beneficial rather than obnoxious or domineering.

Author(S) Details

Reagan F. Cabahug
Davao Medical School Foundation, Philippines and Metro Davao Medical and Research Center, Philippines.

View Book:- https://stm.bookpi.org/NHMMR-V5/article/view/6486

Study on Correlation between Troponin-I Level with Left Ventricular Systolic Dysfunction after First Attack of Non-ST Segment Elevation Myocardial Infarction | Chapter 11 | Highlights on Medicine and Medical Science Vol. 9

 Background: Coronary Heart Disease (CHD) is the most common type of heart disease, and it is the leading cause of death in the developed world. It's crucial to recognise an ACS patient because the diagnosis triggers both triage and treatment. CHD is the cause of more than half of all cardiovascular disease in people. cTnI is a myocardium-specific tissue marker that has been shown to be both sensitive and specific for AMI. Ventricular function is the best predictor of death after an ACS. It's a myocardial damage indicator that also tells you about systolic function, diagnosis, and prognosis. The study's goal was to see if LVEF had an effect on high Troponin-I levels in patients who were having their first NSTEMI event. A cross-sectional analytical study was conducted in the cardiology department of Mymensingh Medical College Hospital from December 2015 to November 2016. A total of 130 first-time NSTEMI patients were included in the study, based on inclusion and exclusion criteria. Two groups of people were chosen from the sample population: Patients in Group I had their first NSTEMI episode and had an LVEF of less than 55%. Group–II: Patients who have had their first NSTEMI incident and have an LVEF of less than 55%. Then, using Pearson's correlation coefficient test, the levels of LVEF and Troponin-I were connected. The mean Troponin-I levels in groups I and II were 5.537.33 and 16.4615.79 ng/ml, respectively, in this investigation. There was a statistically significant difference (p0.05). The mean LVEF for the two groups was 65.3110.30 percent and 40.174.62%, respectively. There was a statistically significant difference (p 0.05). According to echocardiography, patients with a high Troponin-I level had a poor LVEF, while those with a low Troponin-I level had a preserved LVEF. Patients with the highest Troponin-I levels had severe left ventricular systolic dysfunction (LVEF 35%), while those with the lowest levels had severe left ventricular systolic dysfunction (LVEF 35%). Troponin-I levels were low, although systolic function was intact (LVEF was 55%). Troponin-I levels displayed a negative correlate with LVEF levels with a medium strength of association (r= -0.5394, p=0.001), according to our findings. Troponin-I levels of 6.6 ng/ml were also revealed to be a sensitive and specific marker for LV systolic dysfunction in our investigation. Conclusion: The researchers discovered that in NSTEMI patients with their first attack, the higher the Troponin-I level, the lower the LVEF level, and therefore the more severe the LV systolic dysfunction.

Author(s) Details

Dr. Mahmood Hasan Khan
Department of Cardiology, United Hospital Limited, Dhaka, Bangladesh.

Mirza Md. Nazrul Islam
Department of Cardiology, Mymensingh Medical College and Hospital, Mymensingh, Bangladesh.

Md. Shafiqul Islam
Department of Epidemiology, National Institute of Preventive & Social Medicine (NIPSOM), Dhaka, Bangladesh.

Kaisar Nasrullah Khan
Department of Cardiology, United Hospital Limited, Dhaka, Bangladesh.

Md. Shamim Chowdhury

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Reazur Rahman
Department of Cardiology, United Hospital Limited, Dhaka, Bangladesh.


View Book :- https://stm.bookpi.org/HMMS-V9/article/view/2245